Novartis | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 1.46B 1.86B 2025-03
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Bausch Health Companies USD 147M 1.33B 2025-06
Biogen USD 17.63B 655.3M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Canopy Growth CAD 591.48M 81.81M 2024-12
Corcept Therapeutics USD 635.79M 47.49M 2025-06
Drreddys Laboratories INR 317.72B 12.38B 2024-12
Eli Lilly USD 18.27B 2.43B 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
GlaxoSmithKline GBP 14.35B 197M 2025-06
Glaxosmithkline GBP 13.67B 337M 2024-12
J&J USD 78.11B 6.62B 2025-03
Merck USD 49.06B 725M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Novartis USD 44.05B 729M 2024-12
Pacira USD 757.77M 40.77M 2025-06
Perrigo USD 4.47B 108.3M 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Prestige Brands USD 1.86B 20.58M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 70.28B 3.8B 2025-06
Sanofi 77.86B 4.86B 2024-12
Supernus Pharmaceuticals USD 1.06B 33.2M 2025-06
Zoetis USD 4.98B 322M 2025-06


Novartis Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.